SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Dermatological map could lead to new treatments
Fri January 22nd - A newly created skin cell map offers a “huge leap” in understanding of disease and could pave the way for potential drug treatments for painful skin diseases, British researchers say. More
Half a million doctors needed for cancer surgery
Fri January 22nd - The world will need half a million more doctors in the next 20 years, just to cope with growing demand for cancer surgery, according to a major new analysis. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 04/08/2020 VICKY P ADAM wrote:
I would like to thank WORLD HERBS CLINIC for reve... on Medieval remedy for bacterial ...
On 29/07/2020 Amdre wrote:
When i read many blogs online about cure to HSV, a... on Medieval remedy for bacterial ...
On 14/07/2020 margret wrote:
I was diagnosed of ALS (amyotrophic lateral sclero... on Heart abnormalities revealed i...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Effective injectable birth control for men announced

Monday October 31st, 2016

A contraceptive injection for men has been developed successfully, it has been announced.

However, the World Health Organisation (WHO), which was one of the sponsors of the research, said further studies are needed to balance efficacy and safety, after some men reported depression and other mood disorders among the side effects.

The study, which is published in the Journal of Clinical Endocrinology & Metabolism, was a phase II single arm, multi-centre study tested the safety and effectiveness of injectable contraceptives in 320 healthy men ages 18 to 45, all of whom had a normal sperm count when the research began.

They had two injections every eight weeks of 200 milligrams of norethisterone enanthate (NET-EN) and 1,000 milligrams of testosterone undecanoate (TU) for up to 26 weeks to suppress their sperm counts.

Participants provided semen samples after eight and 12 weeks in the suppression phase and then every two weeks until they met the criteria for the next phase.

The men and their partners were instructed to use other non-hormonal birth control methods until their sperm count was less than 1 million/ml in two consecutive tests.

During this efficacy phase, the men received injections every eight weeks for up to 56 weeks and they provided semen samples every eight weeks to ensure their sperm counts stayed low. Once the participants stopped receiving the injections, they were monitored to see how quickly their sperm counts recovered.

The hormones were effective in reducing the sperm count to 1 million/ml or less within 24 weeks in 274 of the participants and the contraceptive method was effective in nearly 96% of continuing users. Only four pregnancies occurred among the men's partners during the efficacy phase of the study.

Side effects included injection site pain, muscle pain, increased libido and acne, but particularly depression and mood disorders, and 20 men dropped out of the study due to side effects.

Dr Philip Reyes Festin, of WHO and one of the study authors, said: “More research is needed to advance this concept to the point that it can be made widely available to men as a method of contraception. Although the injections were effective in reducing the rate of pregnancy, the combination of hormones needs to be studied more to consider a good balance between efficacy and safety.”

Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men. Journal of Clinical Endocrinology & Metabolism 27 October 2016.

Tags: Childbirth and Pregnancy | Men's Health | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES